相关实验视频

Updated: May 22, 2026

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

在胰腺癌中,用于循环微生物转录的CRISPR-Cas13a诊断

Muhammad Shahid Mehmood¹, Inbsaat Iqbal², Fatima Hajj³

¹Institute of Microbiology, University of Agriculture Faisalabad, Faisalabad, Pakistan.

Annals of medicine and surgery (2012)

|January 7, 2026

概括

这项研究提出了一种新的,低成本的胰腺癌诊断工具,使用CRISPR-Cas13a技术和微生物RNA生物标志物. 这种快速液体活检为早期的胰腺管道腺癌检测提供了高准确度.

科学领域:

在瘤学瘤学.
微生物组科学微生物组科学
分子诊断学分子诊断学

背景情况:

胰腺管腺癌 (PDAC) 的预后不佳,大多数病例在晚期被诊断出来.
目前的生物标志物,如CA19-9,缺乏足够的诊断准确性,用于早期检测.
对于PDAC来说,迫切需要精确的,最少侵入性的诊断工具.

研究的目的:

开发一种快速,准确和经济高效的诊断试验,用于早期发现胰腺癌.
将CRISPR-Cas13a技术与微生物RNA生物标记物集成,以改善PDAC诊断.
解决急需改善胰腺癌护理诊断策略的迫切需要.

主要方法:

使用CRISPR-Cas13a,一个具有高灵敏度的RNA引导RNA准系统.
分析微生物转录基因数据以识别PDAC患者血中的细菌RNA片段.
开发一种结合Cas13a平台和特定微生物RNA特征的液体活检测定量.

主要成果:

在CRISPR-Cas13a中,RNA检测表现出对细胞的敏感性和超过95%的诊断准确性.
在PDAC患者的血中发现了明显的细菌RNA片段 (例如,来自*Fusobacterium*, *Enterobacter*).
拟议的综合试验是快速的 (<30分钟) 和低成本的 (<5美元/试验).

结论:

将CRISPR-Cas13a与微生物RNA生物标记物的整合,为PDAC液体活检提供了一种革命性的方法.
这种方法为早期发现胰腺癌提供了高度特定和敏感的测试方法.
该方法融合了微生物组的洞察力,RNA诊断和精确瘤学,以改善患者的治疗结果.

关键词:

这就是CRISPR-Cas13a.在RNA诊断中使用RNA诊断.在循环中的生物标志物.早期检测早期检测液体活检活检液体活检微生物的转录.微生物组是一个微生物组.新的诊断新的诊断胰腺癌是一种癌症.

更多相关视频

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...